吉利德科学(GILD)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

GILD 吉利德科学

盘前交易 01-12 06:30:01 EST

121.10

+0.43

+0.36%

盘前120.32

-0.78-0.64%

05:46 EST

最高122.76	最低119.33	成交量662.95万
今开120.34	昨收120.67	日振幅2.84%
总市值1,502亿	流通市值1,499亿	总股本12.41亿
成交额8.03亿	换手率0.54%	流通股本12.38亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"GILD","market":"US","secType":"STK","nameCN":"吉利德科学","latestPrice":121.1,"timestamp":1767992400000,"preClose":120.67,"halted":0,"volume":6629526,"hourTrading":{"tag":"盘前","latestPrice":120.32,"preClose":121.1,"latestTime":"05:46 EST","volume":801,"amount":96377.645655,"timestamp":1768214797580},"delay":0,"floatShares":1238162880,"shares":1240679623,"eps":6.422841,"marketStatus":"盘前交易","change":0.43,"latestTime":"01-12 06:30:01 EST","open":120.34,"high":122.76,"low":119.33,"amount":803440609.14276,"amplitude":0.028425,"askPrice":121.42,"askSize":100,"bidPrice":120.41,"bidSize":135,"shortable":3,"etf":0,"ttmEps":6.422841,"tradingStatus":1,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1768228200000},"marketStatusCode":1,"adr":0,"adrRate":0,"listingDate":696056400000,"exchange":"NASDAQ","adjPreClose":121.1,"dividendRate":0.025929,"preHourTrading":{"tag":"盘前","latestPrice":120.32,"preClose":121.1,"latestTime":"05:46 EST","volume":801,"amount":96377.645655,"timestamp":1768214797580},"postHourTrading":{"tag":"盘后","latestPrice":121.1,"preClose":121.1,"latestTime":"19:30 EST","volume":265795,"amount":32187892.6876,"timestamp":1768005013267},"volumeRatio":1.0868847724253554,"optionData":{"bulkOrders":[{"symbol":"GILD","call":true,"expireDate":1768539600000,"strike":"130.0","timestamp":1767970693436,"price":0.08,"volume":1097,"amount":8776,"type":"-"}]},"impliedVol":0.2981,"impliedVolPercentile":0.34},"requestUrl":"/m/hq/s/GILD","defaultTab":"news","newsList":[{"id":"2601435481","title":"瑞银上调吉利德科学目标价至145美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2601435481","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2601435481?lang=zh_cn&edition=full","pubTime":"2026-01-08 16:47","pubTimestamp":1767862058,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["IE00B3T34201.USD","BK4583","BK4588","LU1571399168.USD","BK4532","LU1585245621.USD","IE00B19Z3581.USD","BK4566","LU2087621335.USD","IE00B19Z3B42.SGD","IE00B7SZLL34.SGD","LU0320765992.SGD","LU1674673428.USD","LU2089984988.USD","LU1066053197.SGD","IE00BZ1G4Q59.USD","LU0882574055.USD","LU1778281490.HKD","LU0109394709.USD","GILD","IE0002270589.USD","LU0114720955.EUR","LU0889565916.HKD","LU1674673691.USD","SG9999015986.USD","SG9999015978.USD","BK4568","LU1839511570.USD","BK4585","IE00BKVL7J92.USD","SG9999015952.SGD","BK4550","LU2468319806.SGD","LU2324357040.USD","LU0234570918.USD","LU0823416689.USD","LU1066051498.USD","LU1430594728.SGD","SG9999015945.SGD","LU0058720904.USD","LU0289739699.SGD","BK4578","BK4139","IE00BSNM7G36.USD"],"gpt_icon":0},{"id":"1126031375","title":"Onconano Medicine与吉利德科学达成协议扩展选项：后者可通过指定新靶点将合作金额提升至3亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=1126031375","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1126031375?lang=zh_cn&edition=full","pubTime":"2026-01-06 20:12","pubTimestamp":1767701537,"startTime":"0","endTime":"0","summary":"Onconano Medicine近日宣布，其合作伙伴吉利德科学拥有扩展现有合作协议的选项权。根据协议条款，吉利德科学可通过为Onconano Medicine的on-Board技术平台指定额外靶点来触发协议扩展，此举将使Onconano Medicine获得最高达3亿美元的潜在收益。\n该选项机制为双方合作提供了灵活性，既体现了吉利德科学对on-Board技术平台的持续认可，也展现出Onconano Medicine在肿瘤纳米医学领域的创新价值。若吉利德科学行使该选项权，Onconano Medicine将获得包括里程碑付款在内的综合收益，进一步强化其研发资金储备。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0058720904.USD","SG9999015945.SGD","LU0114720955.EUR","BK4568","IE00B19Z3B42.SGD","SG9999015986.USD","LU0823416689.USD","BK4550","LU1674673428.USD","LU1066051498.USD","LU1066053197.SGD","BK4566","IE00B19Z3581.USD","LU1674673691.USD","BK4532","BK4578","SG9999015952.SGD","LU2468319806.SGD","LU1571399168.USD","LU2324357040.USD","LU0882574055.USD","BK4585","IE0002270589.USD","IE00B3T34201.USD","LU0289739699.SGD","BK4139","IE00BZ1G4Q59.USD","LU1585245621.USD","LU2087621335.USD","LU0109394709.USD","LU0234570918.USD","BK4588","LU0889565916.HKD","IE00BSNM7G36.USD","LU1839511570.USD","IE00BKVL7J92.USD","BK4583","LU1778281490.HKD","SG9999015978.USD","GILD","LU2089984988.USD","LU1430594728.SGD","IE00B7SZLL34.SGD","LU0320765992.SGD"],"gpt_icon":0},{"id":"2593047013","title":"美股异动 | 与吉利德科学(GILD.US)达成出售实验性抗癌资产协议 Repare Therapeutics(RPTX.US)盘前一度大涨约20%","url":"https://stock-news.laohu8.com/highlight/detail?id=2593047013","media":"智通财经网","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2593047013?lang=zh_cn&edition=full","pubTime":"2025-12-24 22:19","pubTimestamp":1766585945,"startTime":"0","endTime":"0","summary":"该公司已与吉利德科学达成资产购买协议，收购其实验性抗癌疗法RP-3467，交易总价值最高可达3000万美元","market":"sh","thumbnail":"https://img.zhitongcaijing.com/image/20251224/20251224222230_71916.png?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250","type":0,"news_type":0,"thumbnails":["https://img.zhitongcaijing.com/image/20251224/20251224222230_71916.png?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"09853388b565e5412a3d944672ba7d17","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1385682.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_zhitongcaijin","symbols":["LU1571399168.USD","SG9999015952.SGD","BK4539","IE00BZ1G4Q59.USD","LU0234570918.USD","GILD","LU1674673691.USD","RPTX","LU0114720955.EUR","BK4583","SG9999015978.USD","IE00B19Z3B42.SGD","LU0889565916.HKD","BK4007","IE0002270589.USD","LU0882574055.USD","LU1674673428.USD","LU1066053197.SGD","LU1585245621.USD","LU2089984988.USD","SG9999015945.SGD","BK4568","LU1066051498.USD","BK4588","LU2087621335.USD","LENZ","LU1778281490.HKD","LU0320765992.SGD","IE00BKVL7J92.USD","LU0289739699.SGD","BK4585","IE00B3T34201.USD","IE00BSNM7G36.USD","IE00B7SZLL34.SGD","BK4550","BK4139","LU0109394709.USD","LU1839511570.USD","SG9999015986.USD","IE00B19Z3581.USD","LU1430594728.SGD","BK4566","LU0823416689.USD","BK4578","BK4532","LU0058720904.USD","LU2324357040.USD","LU2468319806.SGD"],"gpt_icon":0},{"id":"1177566900","title":"吉利德科学行使许可选项，以获得Assembly Biosciences针对复发性生殖器疱疹的解旋酶-启动酶抑制剂项目","url":"https://stock-news.laohu8.com/highlight/detail?id=1177566900","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1177566900?lang=zh_cn&edition=full","pubTime":"2025-12-22 21:03","pubTimestamp":1766408625,"startTime":"0","endTime":"0","summary":"吉利德科学行使许可选项，以获得Assembly Biosciences针对复发性生殖器疱疹的解旋酶-启动酶抑制剂项目","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1430594728.SGD","IE00B19Z3581.USD","BK4588","LU0823416689.USD","SG9999015952.SGD","IE00B19Z3B42.SGD","LU0114720955.EUR","LU1674673428.USD","LU2089984988.USD","LU1571399168.USD","IE00B7SZLL34.SGD","BK4550","BK4139","LU1066053197.SGD","LU0882574055.USD","BK4578","LU0289739699.SGD","LU1585245621.USD","BK4566","LU2087621335.USD","SG9999015945.SGD","LU0234570918.USD","BK4583","IE00B3T34201.USD","LU1066051498.USD","BK4532","LU2324357040.USD","LU1674673691.USD","LU0109394709.USD","LU2468319806.SGD","LU0889565916.HKD","BK4568","IE0002270589.USD","LU0058720904.USD","SG9999015978.USD","ASMB","IE00BZ1G4Q59.USD","IE00BKVL7J92.USD","GILD","IE00BSNM7G36.USD","LU0320765992.SGD","SG9999015986.USD","BK4585","LU1839511570.USD","LU1778281490.HKD"],"gpt_icon":0},{"id":"2592139231","title":"默沙东(MRK.US)、施贵宝(BMY.US)等多家药企同意下调美国药价 以换取特朗普政府关税豁免和政策支持","url":"https://stock-news.laohu8.com/highlight/detail?id=2592139231","media":"智通财经","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2592139231?lang=zh_cn&edition=full","pubTime":"2025-12-20 07:00","pubTimestamp":1766185200,"startTime":"0","endTime":"0","summary":"美国总统特朗普推动将美国药价与海外低价市场挂钩之际，多家美国及欧洲大型制药企业近日与白宫达成协议，同意自愿下调在美销售的药品价格，以换取关税豁免和政策支持。在此次协议中，最受市场关注的是施贵宝的让利承诺。特朗普在周五的公开活动上表示，今年7月他致信要求降价的17家大型制药企业中，已有14家同意大幅下调药价。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"2acbaf8fbf691a451fa9ea170ee88816","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1384042.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LU2106854487.HKD","LU1116320737.USD","SG9999015341.SGD","BK4007","BK4588","IE00BLSP4239.USD","LU1093756325.SGD","LU0648001328.SGD","LU0211331839.USD","GILD","LU1941712264.USD","LU1057294990.SGD","IE00BBT3K403.USD","SG9999014575.USD","LU1201861249.SGD","IE0009355771.USD","LU1571399168.USD","LU2023250504.SGD","LU2089984988.USD","LU1035773651.USD","LU1061106388.HKD","LU2468319806.SGD","LU0267386448.USD","LU1023059063.AUD","LU0985320562.USD","IE00B1BXHZ80.USD","LU0098860793.USD","LU2361044865.SGD","LU0289739699.SGD","LU0861579265.USD","LU1989772923.USD","LU2361044949.HKD","LU0096364046.USD","LU1430594728.SGD","BK4532","BMY","AMGN","LU2360032135.SGD","IE00BJT1NW94.SGD","JNJ","LU1093756168.USD","LU0265550359.USD","LU0985481810.HKD","LU1868836914.USD","LU1868836757.USD","SG9999001176.USD","LU0130517989.USD","IE000M9KFDE8.USD","LU0114720955.EUR","IE00BN8TJ469.HKD","LU2324357040.USD","LU2461242641.AUD","LU0265550946.USD","NVS","ABBV","LU1670711040.USD","LU0203347892.USD","LU2125154935.USD","IE00BLSP4452.SGD","LU0456855351.SGD","REGN","LU0203345920.USD","LU2125154778.USD","SG9999002232.USD","LU1868837300.USD","IE00B2B36J28.USD","SG9999014559.SGD","LU1066053197.SGD","BK4533","LU1032466523.USD","SNY","LU1699723380.USD","LU2361045086.USD","LU0965508806.USD","LU0321505439.SGD","LU1670711123.USD","SG9999002224.SGD","BK4550","LU0130102774.USD","LU2133065610.SGD","IE00BFTCPJ56.SGD","LU1323610961.USD","LU1983299246.USD","BK4581","LU0882574055.USD","LU1069347547.HKD","GSK","LU0965509010.AUD","LU0225771236.USD","LU1291159041.SGD","SG9999001176.SGD","SG9999013999.USD","LU0070302665.USD","LU0238689110.USD","SGXZ57979304.SGD","LU1261432733.SGD","LU1934455863.HKD","IE00BJJMRZ35.SGD","LU0237698245.USD","LU0058720904.USD","BK4585","LU0122379950.USD","LU0306806265.USD","LU1929549753.HKD","LU0965509101.SGD","LU0208291251.USD","LU0106261372.USD","SG9999014542.SGD","LU1941712348.USD","LU2242646821.SGD","LU1670710588.SGD","LU1868836591.USD","LU1974910355.USD","BK4559","LU2023250843.SGD","LU1162221912.USD","LU2112291526.USD","LU0225284248.USD","IE00BFXG1179.USD","SG9999001440.SGD","IE0002141913.USD","LU0234572021.USD","LU0306807586.USD","LU1066051498.USD","LU1934455277.USD","LU1116320901.HKD","LU1917777945.USD","LU1989772840.SGD","LU1868837136.USD","LU0965509283.SGD","BK4516","LU2242652126.USD","AZN","LU0061475181.USD","LU1037948897.HKD","LU1074936037.SGD","LU1037948541.HKD","LU1585245621.USD","SG9999015358.SGD","BK4534","LU0320765646.SGD","SG9999014567.USD","LU0006306889.USD","LU0477156953.USD","LU1989771016.USD","LU1670710661.SGD","LU0320765489.SGD","LU1718418525.SGD","MRK","LU1934455194.USD","04332","LU0980610538.SGD","LU1066051811.HKD","ROG","IE00B4R5TH58.HKD","LU0266013472.USD","LU1066051225.USD","LU0868494617.USD","LU0321505868.SGD","IE00BSNM7G36.USD"],"gpt_icon":1},{"id":"1190397083","title":"美国官员称与安进、施贵宝、罗氏旗下基因泰克、吉利德、葛兰素史克、默沙东、诺华、赛诺菲和博瑞诺的交易","url":"https://stock-news.laohu8.com/highlight/detail?id=1190397083","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1190397083?lang=zh_cn&edition=full","pubTime":"2025-12-20 03:22","pubTimestamp":1766172127,"startTime":"0","endTime":"0","summary":"美国官员称与安进、施贵宝、罗氏旗下基因泰克、吉利德、葛兰素史克、默沙东、诺华、赛诺菲和博瑞诺的交易","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BBT3K403.USD","LU2106854487.HKD","LU1116320901.HKD","BK4585","IE00B2B36J28.USD","IE00BZ1G4Q59.USD","BK4550","BK4139","GSK","LU1941712264.USD","IE000M9KFDE8.USD","SG9999015978.USD","LU2023250843.SGD","LU1202635105.USD","LU1015430645.USD","LU0306807586.USD","LU1035777561.USD","LU1674673428.USD","LU0114720955.EUR","SG9999013999.USD","AMGN","BK4534","BK4583","IE00BFTCPJ56.SGD","SG9999014575.USD","IE0002270589.USD","LU1116320737.USD","LU2361045086.USD","SG9999015341.SGD","LU1670710661.SGD","LU0289739699.SGD","LU1261432733.SGD","LU1046248800.SGD","LU2242652126.USD","LU1974910355.USD","LU2360032135.SGD","LU0456855351.SGD","LU0265550946.USD","LU1989772840.SGD","LU1868837300.USD","LU0006306889.USD","LU0965509010.AUD","LU1057294990.SGD","LU0130102774.USD","LU1929549753.HKD","LU1934455863.HKD","LU1934455194.USD","SG9999002232.USD","RHHBY","LU1066051811.HKD","BK4516","BK4568","LU0575583348.USD","LU0238689110.USD","LU1778281490.HKD","LU0868494617.USD","LU0985481810.HKD","IE0034235071.USD","LU0237698245.USD","LU1228905540.USD","LU1670710588.SGD","LU1032466523.USD","BK4581","LU1309081286.SGD","BK4532","LU0225771236.USD","BMY","LU0861579265.USD","LU1064927863.SGD","IE00BJJMRZ35.SGD","LU0971552830.HKD","LU2089984988.USD","LU0882574055.USD","LU1302929846.USD","LU0321505868.SGD","LU0098860793.USD","LU0234572021.USD","IE00BLSP4452.SGD","SG9999014542.SGD","SG9999015945.SGD","LU1162221912.USD","LU0889565916.HKD","IE00BN8TJ469.HKD","SG9999001440.SGD","LU0208291251.USD","LU1941712348.USD","LU0106261372.USD","LU0321505439.SGD","LU0823416689.USD","LU1037948897.HKD","BK4599","04332","LU0130517989.USD","LU0545562505.USD","LU0109981661.USD","LU0965509283.SGD","LU1400636574.HKD","LU1481599808.USD","LU2361044865.SGD","LU1670756490.USD","IE00B19Z3B42.SGD","SG9999014559.SGD","LU0203347892.USD","LU0306806265.USD","LU1718418525.SGD","LU0267386448.USD","LU1989771016.USD","SG9999015952.SGD","IE00BLSP4239.USD","LU1066051498.USD","LU2125154778.USD","IE00B7SZLL34.SGD","LU1670711123.USD","LU0477156953.USD","LU2468319806.SGD","LU0122379950.USD","LU0320765646.SGD","LU1670711040.USD","LU0070302665.USD","IE00B4R5TH58.HKD","LU0265550359.USD","LU1585245621.USD","LU1699723380.USD","IE00BFXG1179.USD","LU0211331839.USD","LU0965509101.SGD","LU2125154935.USD","SG9999001176.USD","LU2133065610.SGD","LU1917777945.USD","LU1066053197.SGD","LU2087621335.USD","LU0971552673.USD","LU1035773651.USD","LU1400636491.USD","LU1069347547.HKD","LU1571399168.USD","BK4566","SG9999014567.USD","LU0096364046.USD","LU1228905037.USD","LU0985320562.USD","LU1868836914.USD","IE00BJT1NW94.SGD","NVS","LU1868837136.USD","LU0203345920.USD","LU1983299246.USD","LU1868836757.USD","LU0965508806.USD","IE00B19Z3581.USD","LU1487256676.USD","LU1291159041.SGD","BK4007","LU0234570918.USD","SGXZ57979304.SGD","IE00BKVL7J92.USD","LU1430594728.SGD","LU0225284248.USD","LU1066051225.USD","IE00BSNM7G36.USD","BIIB","LU1989772923.USD","LU0061475181.USD","SG9999001176.SGD","IE00BWDBJ516.SGD","LU1868836591.USD","LU2324357040.USD","LU2461242641.AUD","SNY","SG9999015358.SGD","LU1201861249.SGD","LU1061106388.HKD","LU1023059063.AUD","LU2242646821.SGD","IE00B1BXHZ80.USD","LU0109394709.USD","LU1323610961.USD","IE00BQJZX424.USD","LU1839511570.USD","LU2361044949.HKD","LU2112291526.USD","LU1037948541.HKD","LU1481600234.SGD","SG9999002224.SGD","BK4588","LU0980610538.SGD","BK4559","LU1400636657.SGD","BK4578","SG9999015986.USD","LU0161305163.EUR","BK5011","LU1074936037.SGD","LU1093756168.USD","LU1934455277.USD","LU1093756325.SGD","IE00B3T34201.USD","LU2023250504.SGD","MRK","LU0058720904.USD","IE0002141913.USD","LU0320765992.SGD","LU1098665638.USD","LU1645745479.HKD","GILD","BK4533","LU1674673691.USD","LU0648001328.SGD","LU0266013472.USD","LU0320765489.SGD","IE0009355771.USD"],"gpt_icon":0},{"id":"1185501574","title":"公司将通过Trumprx网站以更低价格直接向消费者提供多种药物-美国官员","url":"https://stock-news.laohu8.com/highlight/detail?id=1185501574","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1185501574?lang=zh_cn&edition=full","pubTime":"2025-12-20 03:21","pubTimestamp":1766172084,"startTime":"0","endTime":"0","summary":"公司将通过Trumprx网站以更低的价格向消费者直接提供多种药物-美国官员","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE0002141913.USD","SG9999015978.USD","LU0096364046.USD","IE00B2B36J28.USD","LU0234572021.USD","LU0265550359.USD","IE00BJJMRZ35.SGD","BK4139","LU0980610538.SGD","GILD","SG9999002224.SGD","LU1670710661.SGD","IE00B4R5TH58.HKD","BK4534","LU0237698245.USD","LU1571399168.USD","LU1934455194.USD","LU1302929846.USD","LU0109981661.USD","LU1487256676.USD","LU1670710588.SGD","LU0006306889.USD","LU0575583348.USD","LU0211331839.USD","LU1032466523.USD","LU1400636491.USD","LU1061106388.HKD","BK4516","IE000M9KFDE8.USD","IE00B7SZLL34.SGD","LU0208291251.USD","LU0965509010.AUD","BK4532","LU0225284248.USD","LU0234570918.USD","LU0321505439.SGD","SG9999014559.SGD","SG9999002232.USD","BK4581","LU0114720955.EUR","SG9999015358.SGD","BMY","SG9999001176.SGD","IE00B19Z3581.USD","LU0965509101.SGD","LU0106261372.USD","BK4533","LU1228905540.USD","LU1430594728.SGD","LU1645745479.HKD","LU1868837136.USD","LU1035773651.USD","LU0122379950.USD","IE00B3T34201.USD","IE00BJT1NW94.SGD","04332","BK4585","TRUMP","LU1162221912.USD","IE00BFXG1179.USD","LU2023250843.SGD","IE00BFTCPJ56.SGD","LU1046248800.SGD","LU0456855351.SGD","SG9999014542.SGD","LU1323610961.USD","LU0266013472.USD","LU1202635105.USD","LU0289739699.SGD","IE00BLSP4239.USD","BK4588","LU0320765992.SGD","LU2242646821.SGD","LU2324357040.USD","LU0058720904.USD","LU1929549753.HKD","LU1941712264.USD","LU0238689110.USD","LU2133065610.SGD","LU1585245621.USD","IE00BN8TJ469.HKD","LU2242652126.USD","IE0034235071.USD","MRK","LU1989771016.USD","LU1778281490.HKD","LU1934455277.USD","IE00BQJZX424.USD","BK4583","IE00BWDBJ516.SGD","SG9999015945.SGD","LU1098665638.USD","BK4566","LU0161305163.EUR","LU0477156953.USD","LU1400636574.HKD","LU0109394709.USD","LU1868836914.USD","LU2112291526.USD","LU1066051811.HKD","LU0320765646.SGD","IE00B1BXHZ80.USD","LU1074936037.SGD","LU1116320737.USD","LU0861579265.USD","AMGN","LU1309081286.SGD","GSK","LU1983299246.USD","LU1917777945.USD","SG9999014567.USD","LU0203345920.USD","LU1057294990.SGD","LU2360032135.SGD","IE00B19Z3B42.SGD","BK4007","LU1064927863.SGD","LU2468319806.SGD","IE00BBT3K403.USD","SG9999013999.USD","SG9999015341.SGD","LU1066051498.USD","BK4599","LU1989772923.USD","BK5011","LU0130102774.USD","LU0320765489.SGD","LU1974910355.USD","LU1261432733.SGD","LU1035777561.USD","LU0985320562.USD","LU0061475181.USD","LU0868494617.USD","LU0267386448.USD","LU1670711123.USD","IE0009355771.USD","LU1839511570.USD","BK4578","LU0203347892.USD","LU1037948897.HKD","IE0002270589.USD","LU1868837300.USD","LU2087621335.USD","LU2125154778.USD","SGXZ57979304.SGD","LU2106854487.HKD","SG9999001176.USD","LU2125154935.USD","LU1023059063.AUD","LU0889565916.HKD","LU1015430645.USD","LU0545562505.USD","LU1670756490.USD","LU1674673428.USD","LU1481600234.SGD","IE00BLSP4452.SGD","LU1699723380.USD","LU0098860793.USD","LU1093756168.USD","SG9999001440.SGD","LU1868836591.USD","LU0306807586.USD","IE00BKVL7J92.USD","IE00BZ1G4Q59.USD","LU0225771236.USD","LU1868836757.USD","LU1066051225.USD","LU2089984988.USD","SG9999014575.USD","BK4568","LU1481599808.USD","LU0965508806.USD","LU1718418525.SGD","LU0971552673.USD","LU1674673691.USD","LU1670711040.USD","LU0971552830.HKD","LU0985481810.HKD","LU1989772840.SGD","LU2361044949.HKD","LU0965509283.SGD","LU0823416689.USD","LU1116320901.HKD","LU1934455863.HKD","LU0070302665.USD","LU0306806265.USD","LU1291159041.SGD","LU0265550946.USD","SG9999015986.USD","LU0321505868.SGD","LU2023250504.SGD","LU2361044865.SGD","LU2461242641.AUD","LU1201861249.SGD","BK4559","IE00BSNM7G36.USD","LU1093756325.SGD","LU2361045086.USD","LU1037948541.HKD","LU1400636657.SGD","LU1228905037.USD","LU1941712348.USD","LU0648001328.SGD","LU1069347547.HKD","LU1066053197.SGD","SG9999015952.SGD","LU0882574055.USD","BK4550","LU0130517989.USD"],"gpt_icon":0},{"id":"1119342602","title":"多家制造商同意向美国战略储备捐赠活性药物成分","url":"https://stock-news.laohu8.com/highlight/detail?id=1119342602","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1119342602?lang=zh_cn&edition=full","pubTime":"2025-12-20 03:20","pubTimestamp":1766172037,"startTime":"0","endTime":"0","summary":"多家制造商同意向美国战略储备捐赠活性药物成分。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1201861249.SGD","LU1069347547.HKD","LU1989771016.USD","IE0034235071.USD","04332","IE00BKVL7J92.USD","LU2023250504.SGD","LU0237698245.USD","LU2361044865.SGD","LU2242652126.USD","SG9999015358.SGD","SG9999015945.SGD","LU2361045086.USD","LU1023059063.AUD","LU1098665638.USD","SG9999001176.USD","LU2468319806.SGD","LU0823416689.USD","LU1430594728.SGD","LU0208291251.USD","LU0306807586.USD","LU0965508806.USD","BK4568","LU0265550359.USD","LU1046248800.SGD","BK4599","LU2242646821.SGD","LU1674673691.USD","LU2125154778.USD","LU1093756325.SGD","IE0009355771.USD","LU1035773651.USD","LU0109394709.USD","LU1057294990.SGD","LU1934455863.HKD","LU1015430645.USD","LU1037948897.HKD","LU0265550946.USD","LU1674673428.USD","LU0114720955.EUR","LU0882574055.USD","MRK","SG9999001176.SGD","LU1974910355.USD","LU1989772923.USD","LU0648001328.SGD","LU1868836757.USD","BK4532","LU0320765489.SGD","AMGN","IE00BZ1G4Q59.USD","LU1585245621.USD","LU1670711040.USD","LU0058720904.USD","LU0861579265.USD","LU1037948541.HKD","LU1400636574.HKD","LU0320765992.SGD","LU1228905037.USD","BK4533","LU0868494617.USD","LU1917777945.USD","LU0238689110.USD","LU0266013472.USD","LU2361044949.HKD","IE00B2B36J28.USD","IE0002270589.USD","IE00B4R5TH58.HKD","IE00B7SZLL34.SGD","LU0234572021.USD","LU1302929846.USD","LU0971552673.USD","LU1400636491.USD","LU1670711123.USD","LU2089984988.USD","LU0006306889.USD","SG9999014542.SGD","LU1868836591.USD","LU1670710588.SGD","LU1839511570.USD","SG9999014575.USD","GILD","BK4550","BMY","LU1645745479.HKD","LU2324357040.USD","LU0306806265.USD","LU0321505868.SGD","LU0203347892.USD","SGXZ57979304.SGD","LU1066053197.SGD","LU1202635105.USD","IE00BJJMRZ35.SGD","LU1868837300.USD","BK4585","LU0106261372.USD","SG9999013999.USD","IE00BWDBJ516.SGD","IE00BJT1NW94.SGD","LU1323610961.USD","LU0889565916.HKD","LU2461242641.AUD","LU1571399168.USD","LU1162221912.USD","LU1670756490.USD","BK4516","SG9999002224.SGD","LU0211331839.USD","LU1699723380.USD","BK4559","LU1481599808.USD","BK4583","LU0267386448.USD","LU0965509101.SGD","IE0002141913.USD","IE00BLSP4239.USD","LU1066051811.HKD","IE00B19Z3581.USD","LU0289739699.SGD","LU0070302665.USD","LU1941712264.USD","LU0985481810.HKD","LU2360032135.SGD","LU0161305163.EUR","LU2023250843.SGD","LU1061106388.HKD","IE00BSNM7G36.USD","LU1934455277.USD","SG9999015341.SGD","LU0203345920.USD","LU1291159041.SGD","LU1400636657.SGD","LU1074936037.SGD","LU0130102774.USD","BK4578","SG9999014559.SGD","LU0225771236.USD","LU0980610538.SGD","LU0971552830.HKD","LU1868837136.USD","LU2125154935.USD","BK5011","LU1670710661.SGD","IE00BBT3K403.USD","LU0109981661.USD","IE00BFTCPJ56.SGD","LU0130517989.USD","IE00B3T34201.USD","LU0321505439.SGD","IE00BQJZX424.USD","LU0122379950.USD","IE000M9KFDE8.USD","LU1868836914.USD","IE00B1BXHZ80.USD","LU0965509283.SGD","BK4007","IE00BN8TJ469.HKD","SG9999001440.SGD","LU0320765646.SGD","LU2112291526.USD","LU0061475181.USD","IE00BLSP4452.SGD","BK4588","BK4534","LU1064927863.SGD","LU1035777561.USD","SG9999015978.USD","LU0985320562.USD","LU1093756168.USD","SG9999002232.USD","LU1116320737.USD","LU1032466523.USD","GSK.UK","IE00B19Z3B42.SGD","LU0575583348.USD","IE00BFXG1179.USD","LU1487256676.USD","LU1983299246.USD","LU2106854487.HKD","LU1066051498.USD","LU0096364046.USD","LU0965509010.AUD","LU1261432733.SGD","LU1929549753.HKD","SG9999015952.SGD","BK4139","LU1066051225.USD","LU1989772840.SGD","BK4566","SG9999015986.USD","LU1934455194.USD","LU0477156953.USD","LU1309081286.SGD","LU0234570918.USD","LU1481600234.SGD","LU1941712348.USD","BK4581","LU0098860793.USD","LU1116320901.HKD","LU0456855351.SGD","LU1228905540.USD","LU1718418525.SGD","LU2133065610.SGD","LU2087621335.USD","LU1778281490.HKD","LU0225284248.USD","LU0545562505.USD","SG9999014567.USD"],"gpt_icon":0},{"id":"2592902308","title":"III期ARTISTRY-2研究达主要终点，吉利德新型HIV二联疗法展现潜力","url":"https://stock-news.laohu8.com/highlight/detail?id=2592902308","media":"药事纵横","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2592902308?lang=zh_cn&edition=full","pubTime":"2025-12-18 07:05","pubTimestamp":1766012717,"startTime":"0","endTime":"0","summary":"12月15日，吉利德宣布III期ARTISTRY-2研究取得积极顶线结果。吉利德计划将ARTISTRY研究的III期结果提交给监管机构，并将在未来的科学大会上公布详细数据。在ARTISTRY-2研究中，每日一次的单片复方方案BIC/LEN达到了主要成功标准，其疗效非劣于BIKTARVY。ARTISTRY-2的研究结果将与III期ARTISTRY-1研究的发现共同构成监管申报的基础。吉利德已于2025年11月公布了ARTISTRY-1的顶线结果，显示BIC/LEN组合耐受性良好，在疗效上非劣于多片式抗反转录病毒治疗方案。目前尚无治愈HIV或艾滋病的方法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251218071039a6afa5d0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251218071039a6afa5d0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LU0320765992.SGD","LU0058720904.USD","LU0109394709.USD","BK4583","BK4578","SG9999015986.USD","BK4588","LU2324357040.USD","LU1674673428.USD","IE00B19Z3B42.SGD","LU0823416689.USD","BK4550","BK4585","LU0114720955.EUR","LU1066051498.USD","LU0882574055.USD","BK4134","IE00BZ1G4Q59.USD","LU0234570918.USD","BK4566","IE00B19Z3581.USD","LU2089984988.USD","BK4568","IE00B3T34201.USD","SG9999015952.SGD","LU0889565916.HKD","IE00BKVL7J92.USD","LU1066053197.SGD","III","LU0289739699.SGD","GILD","LU1778281490.HKD","LU1839511570.USD","SG9999015978.USD","LU1571399168.USD","BK4532","IE00B7SZLL34.SGD","LU1430594728.SGD","LU1674673691.USD","LU1585245621.USD","BK4139","LU2468319806.SGD","IE0002270589.USD","IE00BSNM7G36.USD","SG9999015945.SGD","LU2087621335.USD"],"gpt_icon":0},{"id":"1132993871","title":"吉利德科学针对HIV治疗的比克替普和莱那替韦单片疗法在第三阶段ARTISTRY-2试验中达到主要终点","url":"https://stock-news.laohu8.com/highlight/detail?id=1132993871","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1132993871?lang=zh_cn&edition=full","pubTime":"2025-12-15 21:32","pubTimestamp":1765805534,"startTime":"0","endTime":"0","summary":"吉利德科学针对HIV治疗的比克替普和莱那替韦单片疗法在第三阶段ARTISTRY-2试验中达到主要终点","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4532","BK4566","LU1066053197.SGD","BK4550","IE00BKVL7J92.USD","LU0109394709.USD","IE00B7SZLL34.SGD","SG9999015952.SGD","IE00BSNM7G36.USD","SG9999015945.SGD","LU1430594728.SGD","LU0114720955.EUR","LU0823416689.USD","LU0889565916.HKD","BK4578","BK4139","LU1066051498.USD","IE00B19Z3B42.SGD","LU0234570918.USD","BK4588","LU1839511570.USD","LU1571399168.USD","LU2089984988.USD","BK4583","LU1585245621.USD","IE00B3T34201.USD","BK4568","LU1778281490.HKD","SG9999015978.USD","SG9999015986.USD","IE0002270589.USD","IE00BZ1G4Q59.USD","BK4585","LU0289739699.SGD","LU1674673428.USD","LU0058720904.USD","LU2087621335.USD","GILD","LU2468319806.SGD","LU0320765992.SGD","LU0882574055.USD","LU1674673691.USD","IE00B19Z3581.USD","LU2324357040.USD"],"gpt_icon":0},{"id":"1123601921","title":"吉利德科学 - 中期分析显示，Domvanalimab与Zimberelimab及化疗的组合相较于Nivolumab与化疗并未改善总生存期","url":"https://stock-news.laohu8.com/highlight/detail?id=1123601921","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1123601921?lang=zh_cn&edition=full","pubTime":"2025-12-12 21:29","pubTimestamp":1765546157,"startTime":"0","endTime":"0","summary":"吉利德科学 - 中期分析显示，Domvanalimab与Zimberelimab及化疗的组合相较于Nivolumab与化疗并未改善总生存期","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BZ1G4Q59.USD","LU1778281490.HKD","BK4568","IE00BSNM7G36.USD","SG9999015978.USD","LU0114720955.EUR","LU0234570918.USD","LU0882574055.USD","SG9999015986.USD","GILD","SG9999015945.SGD","IE0002270589.USD","LU0289739699.SGD","LU0823416689.USD","BK4550","BK4583","LU1066053197.SGD","BK4585","LU2089984988.USD","BK4139","IE00B7SZLL34.SGD","IE00B3T34201.USD","LU0889565916.HKD","BK4532","IE00BKVL7J92.USD","LU1674673691.USD","BK4588","LU0320765992.SGD","IE00B19Z3B42.SGD","LU2324357040.USD","LU1571399168.USD","LU0109394709.USD","LU1430594728.SGD","BK4566","LU1839511570.USD","LU1674673428.USD","LU1066051498.USD","BK4578","LU2087621335.USD","LU1585245621.USD","LU2468319806.SGD","LU0058720904.USD","SG9999015952.SGD","IE00B19Z3581.USD"],"gpt_icon":0},{"id":"2590451393","title":"吉利德Anito-cel 神经毒性低，2年多发性骨髓瘤生存率高 | ASH25","url":"https://stock-news.laohu8.com/highlight/detail?id=2590451393","media":"Minhua笔记","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2590451393?lang=zh_cn&edition=full","pubTime":"2025-12-08 11:58","pubTimestamp":1765166299,"startTime":"0","endTime":"0","summary":"在ASH 2025年会上，吉利德旗下Kite Pharma公布Anito-cel在iMMagine-1 II期试验中的更新数据，该靶向BCMA的CAR-T疗法在复发/难治性多发性骨髓瘤患者中显示96% ORR、74% sCR/CR率、95% MRD阴性率，中位随访15.9个月，缓解持续。III期iMMagine-3试验正在招募中，该研究将Anito-cel与标准治疗比较，预计2026年获得数据；该药物获FDA快速通道、孤儿药和RMAT资格。ICANS 发生率为 8%，其中 1 例为 3 级；其余均为 2 级或更低。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251208144817a43ac231&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251208144817a43ac231&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["GILD","BK4097","BK4566","BK4139","IE00BZ1G4Q59.USD","IE00B19Z4B17.USD","LU0889565916.HKD","LU1571399168.USD","LU1839511570.USD","SG9999015986.USD","ASH","IE00BKVL7J92.USD","SG9999015978.USD","LU0882574055.USD","LU1585245621.USD","LU0234570918.USD","SG9999015952.SGD","BK4568","IE0002270589.USD","IE00B7SZL793.SGD","CRS","LU1430594728.SGD","IE00B19Z3B42.SGD","CR","BK4195","LU0823416689.USD","LU1778281490.HKD","LU0289739699.SGD","BK4550","IE00B19Z3581.USD","BK4578","SG9999015945.SGD","IE00B7SZLL34.SGD","IE00B66KJ199.SGD","BK4109","ORR","PFS","LU1674673691.USD","BK4585","BK4532","LU0320765992.SGD","KOL","BK4187","LU1066051498.USD","LU1674673428.USD","BK4588","OS","LU0109394709.USD","IE00B3T34201.USD"],"gpt_icon":0},{"id":"1151810716","title":"Aspen Neuroscience：C轮融资由Orbimed、Arch Venture Partners等共同牵头，S32、Axon Ventures、Kite等参与投资","url":"https://stock-news.laohu8.com/highlight/detail?id=1151810716","media":"美股速递","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1151810716?lang=zh_cn&edition=full","pubTime":"2025-11-20 20:19","pubTimestamp":1763641183,"startTime":"0","endTime":"0","summary":"Aspen Neuroscience：C轮融资由Orbimed、Arch Venture Partners等共同牵头，S32、Axon Ventures、Kite等参与投资","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","LU2087621335.USD","LU1430594728.SGD","BK4568","BK4578","IE00BSNM7G36.USD","IE00B19Z3581.USD","BK4588","BK4139","LU1066051498.USD","IE00BZ1G4Q59.USD","IE00B7SZLL34.SGD","GILD","IE0002270589.USD","LU2324357040.USD","LU0109394709.USD","LU0289739699.SGD","LU1585245621.USD","LU1839511570.USD","LU2089984988.USD","LU0889565916.HKD","SG9999015978.USD","BK4550","BK4532","LU0114720955.EUR","LU1674673691.USD","LU0234570918.USD","LU1778281490.HKD","LU0058720904.USD","BK4566","LU1066053197.SGD","IE00BKVL7J92.USD","LU1674673428.USD","LU0320765992.SGD","LU2468319806.SGD","SG9999015945.SGD","LU0882574055.USD","LU1571399168.USD","BK4583","SG9999015986.USD","IE00B19Z3B42.SGD","LU0823416689.USD","SG9999015952.SGD","IE00B3T34201.USD"],"gpt_icon":0},{"id":"1104987976","title":"Aspen Neuroscience 宣布1.15亿美元C轮融资以加速个性化细胞治疗项目","url":"https://stock-news.laohu8.com/highlight/detail?id=1104987976","media":"美股速递","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1104987976?lang=zh_cn&edition=full","pubTime":"2025-11-20 20:17","pubTimestamp":1763641028,"startTime":"0","endTime":"0","summary":"Aspen Neuroscience 宣布完成1.15亿美元的C轮融资，旨在加速其个性化细胞治疗项目的发展。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SG9999015952.SGD","LU1066053197.SGD","IE00BKVL7J92.USD","LU1674673428.USD","IE00BZ1G4Q59.USD","BK4566","LU0234570918.USD","LU0320765992.SGD","LU0889565916.HKD","BK4139","BK4550","BK4578","BK4585","LU2087621335.USD","LU2089984988.USD","GILD","LU0114720955.EUR","IE00B7SZLL34.SGD","SG9999015986.USD","LU2324357040.USD","IE00BSNM7G36.USD","LU1571399168.USD","LU1778281490.HKD","LU1839511570.USD","SG9999015978.USD","LU2468319806.SGD","LU0289739699.SGD","BK4532","LU1430594728.SGD","SG9999015945.SGD","LU0058720904.USD","LU1585245621.USD","LU0109394709.USD","LU0823416689.USD","IE00B3T34201.USD","IE00B19Z3B42.SGD","BK4588","BK4583","LU0882574055.USD","BK4568","LU1674673691.USD","IE0002270589.USD","IE00B19Z3581.USD","LU1066051498.USD"],"gpt_icon":0},{"id":"1142384908","title":"吉利德科学更新ASCENT-07三期研究进展","url":"https://stock-news.laohu8.com/highlight/detail?id=1142384908","media":"投资观察","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1142384908?lang=zh_cn&edition=full","pubTime":"2025-11-20 01:10","pubTimestamp":1763572211,"startTime":"0","endTime":"0","summary":"11月7日 - 吉利德科学公司发布了其ASCENT-07三期研究的更新：该研究未能达到无病进展生存期的主要终点；安全性资料与之前对Trodelvy乳腺癌的研究一致，且在该患者群体中未发现新的安全性信号。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0320765992.SGD","LU1571399168.USD","LU1585245621.USD","LU2089984988.USD","LU0109394709.USD","LU0289739699.SGD","BK4139","LU1430594728.SGD","LU1674673428.USD","IE00B3T34201.USD","LU2087621335.USD","SG9999015978.USD","BK4578","IE00BZ1G4Q59.USD","LU0889565916.HKD","BK4550","BK4588","IE00BSNM7G36.USD","LU1674673691.USD","BK4585","SG9999015945.SGD","IE0002270589.USD","BK4568","BK4532","LU0114720955.EUR","GILD","IE00B19Z3B42.SGD","LU1778281490.HKD","SG9999015952.SGD","LU2324357040.USD","SG9999015986.USD","IE00BKVL7J92.USD","LU0882574055.USD","BK4566","LU0234570918.USD","LU0823416689.USD","IE00B7SZLL34.SGD","LU1066053197.SGD","LU1066051498.USD","LU1839511570.USD","LU2468319806.SGD","BK4583","IE00B19Z3581.USD","LU0058720904.USD"],"gpt_icon":0},{"id":"1100305925","title":"吉利德科学 - 泰尔曼将于12月5日起不再担任公司事务和总法律顾问执行副总裁","url":"https://stock-news.laohu8.com/highlight/detail?id=1100305925","media":"美股速递","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1100305925?lang=zh_cn&edition=full","pubTime":"2025-11-19 21:34","pubTimestamp":1763559269,"startTime":"0","endTime":"0","summary":"吉利德科学 - 泰尔曼将于12月5日起不再担任公司事务和总法律顾问执行副总裁","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SG9999015952.SGD","LU0882574055.USD","BK4578","BK4588","SG9999015978.USD","IE00B7SZLL34.SGD","LU0234570918.USD","IE00B3T34201.USD","LU2087621335.USD","BK4568","BK4585","IE00BSNM7G36.USD","LU0289739699.SGD","LU0058720904.USD","BK4532","LU1778281490.HKD","BK4583","SG9999015986.USD","BK4139","IE00BKVL7J92.USD","LU1430594728.SGD","LU1839511570.USD","IE0002270589.USD","LU1674673428.USD","LU2089984988.USD","LU0114720955.EUR","SG9999015945.SGD","BK4550","LU2468319806.SGD","LU2324357040.USD","IE00B19Z3581.USD","LU0889565916.HKD","IE00BZ1G4Q59.USD","LU1585245621.USD","LU1066051498.USD","IE00B19Z3B42.SGD","LU1674673691.USD","LU0823416689.USD","GILD","LU0320765992.SGD","LU1066053197.SGD","BK4566","LU1571399168.USD","LU0109394709.USD"],"gpt_icon":0},{"id":"1188771558","title":"吉利德科学的单片剂方案在III期ARTISTRY-1试验中达到主要终点","url":"https://stock-news.laohu8.com/highlight/detail?id=1188771558","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1188771558?lang=zh_cn&edition=full","pubTime":"2025-11-13 21:31","pubTimestamp":1763040716,"startTime":"0","endTime":"0","summary":"吉利德科学的单片剂方案Bictegravir和Lenacapavir用于HIV-1治疗在III期ARTISTRY-1试验中达到了主要终点。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SG9999015952.SGD","LU1066053197.SGD","IE00BKVL7J92.USD","LU1674673428.USD","IE00BZ1G4Q59.USD","BK4566","LU0234570918.USD","LU0320765992.SGD","LU0889565916.HKD","BK4139","BK4550","BK4578","BK4585","LU2087621335.USD","LU2089984988.USD","GILD","LU0114720955.EUR","IE00B7SZLL34.SGD","SG9999015986.USD","LU2324357040.USD","IE00BSNM7G36.USD","LU1571399168.USD","LU1778281490.HKD","LU1839511570.USD","SG9999015978.USD","LU2468319806.SGD","LU0289739699.SGD","BK4532","LU1430594728.SGD","SG9999015945.SGD","LU0058720904.USD","LU1585245621.USD","LU0109394709.USD","LU0823416689.USD","IE00B3T34201.USD","IE00B19Z3B42.SGD","BK4588","BK4583","LU0882574055.USD","BK4568","LU1674673691.USD","IE0002270589.USD","IE00B19Z3581.USD","LU1066051498.USD"],"gpt_icon":0},{"id":"1157913444","title":"吉利德科学首席财务官表示公司将继续积极开展业务发展，包括许可和并购","url":"https://stock-news.laohu8.com/highlight/detail?id=1157913444","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1157913444?lang=zh_cn&edition=full","pubTime":"2025-11-11 00:35","pubTimestamp":1762792519,"startTime":"0","endTime":"0","summary":"吉利德科学首席财务官表示公司将继续积极开展业务发展，包括许可和并购。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["GILD","BK4566","BK4139","IE00BZ1G4Q59.USD","LU0058720904.USD","LU1571399168.USD","LU0889565916.HKD","LU1839511570.USD","LU1066053197.SGD","SG9999015986.USD","IE00BKVL7J92.USD","SG9999015978.USD","LU0882574055.USD","LU1585245621.USD","LU0234570918.USD","SG9999015952.SGD","BK4568","IE0002270589.USD","LU1430594728.SGD","IE00B19Z3B42.SGD","LU2089984988.USD","LU0823416689.USD","LU2087621335.USD","LU1778281490.HKD","LU0289739699.SGD","LU0114720955.EUR","BK4550","IE00B19Z3581.USD","BK4578","SG9999015945.SGD","IE00B7SZLL34.SGD","LU1674673691.USD","IE00BSNM7G36.USD","BK4585","LU2468319806.SGD","BK4532","LU0320765992.SGD","LU1066051498.USD","LU1674673428.USD","BK4583","BK4588","LU0109394709.USD","IE00B3T34201.USD","LU2324357040.USD"],"gpt_icon":0},{"id":"1145102354","title":"吉利德科学首席财务官表示医保改革对艾滋病业务影响约为9亿美元，整体业务影响达12亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=1145102354","media":"美股速递","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1145102354?lang=zh_cn&edition=full","pubTime":"2025-11-11 00:13","pubTimestamp":1762791201,"startTime":"0","endTime":"0","summary":"吉利德科学首席财务官表示，医保改革对艾滋病业务的影响约为9亿美元，整体业务的影响则达到12亿美元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","BK4588","BK4139","LU1430594728.SGD","IE00B19Z3581.USD","LU2468319806.SGD","LU0109394709.USD","IE00BZ1G4Q59.USD","LU0320765992.SGD","LU1066053197.SGD","BK4578","LU1571399168.USD","LU2089984988.USD","LU0823416689.USD","BK4532","IE00B3T34201.USD","BK4566","IE00B7SZLL34.SGD","LU0889565916.HKD","LU0882574055.USD","LU2087621335.USD","LU1839511570.USD","IE00BKVL7J92.USD","LU1674673428.USD","SG9999015945.SGD","LU0289739699.SGD","LU0234570918.USD","LU1778281490.HKD","BK4568","LU1066051498.USD","IE0002270589.USD","BK4550","IE00B19Z3B42.SGD","LU1585245621.USD","IE00BSNM7G36.USD","LU0058720904.USD","LU1674673691.USD","LU2324357040.USD","SG9999015952.SGD","LU0114720955.EUR","SG9999015978.USD","SG9999015986.USD","GILD","BK4583"],"gpt_icon":0},{"id":"2582862418","title":"吉利德：Trop2 ADC一线治疗HR+/HER2-乳腺三期临床失败","url":"https://stock-news.laohu8.com/highlight/detail?id=2582862418","media":"医药笔记","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2582862418?lang=zh_cn&edition=full","pubTime":"2025-11-08 09:31","pubTimestamp":1762565499,"startTime":"0","endTime":"0","summary":"▎Armstrong2025年11月7日，吉利德宣布Trop2 ADC新药Trodelvy对比化疗一线治疗内分泌治疗后HR+/HER2-乳腺癌的三期临床ASCENT-07没有达到PFS主要终点，关键次要终点OS尚未成熟，但观察到获益趋势，研究将继续进行以评估OS数据。Trodelvy一线治疗三阴乳腺癌已经递交上市申请。总结吉利德Trodelvy为全球首款Trop2 ADC，但作为上一代ADC在适应症拓展的道路上充满曲折，先后在非小细胞肺癌、尿路上皮癌失败，此次HR+/HER2-乳腺癌又错失PFS终点，仅守住三阴乳腺癌这一阵地。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251108093356a6e9fd53&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251108093356a6e9fd53&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IE00B19Z3B42.SGD","BK4585","BK4203","IE00BZ1G4Q59.USD","SG9999015952.SGD","BK4568","BK4550","BK4139","LU1066051498.USD","LU1778281490.HKD","HR","LU0109394709.USD","BK4080","IE00B7SZLL34.SGD","SG9999015978.USD","LU2468319806.SGD","LU1839511570.USD","BK4532","LU1585245621.USD","BK4588","LU1674673428.USD","BK4578","ADC","LU2089984988.USD","SG9999015986.USD","LU0114720955.EUR","LU1066053197.SGD","LU2087621335.USD","BK4225","LU1571399168.USD","BK4566","LU0882574055.USD","BK4583","IE00B3T34201.USD","LU0058720904.USD","IE0002270589.USD","LU0289739699.SGD","LU0320765992.SGD","IE00B19Z3581.USD","SG9999015945.SGD","GILD","LU0234570918.USD","LU0889565916.HKD","IE00BKVL7J92.USD","LU1430594728.SGD","IE00BSNM7G36.USD","LU1674673691.USD","LU0823416689.USD","BK4231","LU2324357040.USD"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.gilead.com","stockEarnings":[{"period":"1week","weight":-0.0041},{"period":"1month","weight":-0.002},{"period":"3month","weight":0.0335},{"period":"6month","weight":0.1045},{"period":"1year","weight":0.3585},{"period":"ytd","weight":-0.0134}],"compareEarnings":[{"period":"1week","weight":0.016},{"period":"1month","weight":0.0095},{"period":"3month","weight":0.0629},{"period":"6month","weight":0.113},{"period":"1year","weight":0.1774},{"period":"ytd","weight":0.0178}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"吉利德科学公司于1987年6月22日在特拉华州成立，是一家以研究为基础的生物制药公司，致力于发现，开发和商业化未满足医疗需求的创新药物。该公司的主要重点领域包括病毒性疾病，炎性和纤维化疾病以及肿瘤学。","yearOnYearQuotes":[{"month":1,"riseRate":0.558824,"avgChangeRate":0.039919},{"month":2,"riseRate":0.411765,"avgChangeRate":0.007165},{"month":3,"riseRate":0.529412,"avgChangeRate":-0.009708},{"month":4,"riseRate":0.529412,"avgChangeRate":0.011973},{"month":5,"riseRate":0.558824,"avgChangeRate":0.0204},{"month":6,"riseRate":0.647059,"avgChangeRate":0.025673},{"month":7,"riseRate":0.558824,"avgChangeRate":0.01609},{"month":8,"riseRate":0.558824,"avgChangeRate":0.033158},{"month":9,"riseRate":0.558824,"avgChangeRate":0.031157},{"month":10,"riseRate":0.529412,"avgChangeRate":0.003173},{"month":11,"riseRate":0.647059,"avgChangeRate":0.039736},{"month":12,"riseRate":0.382353,"avgChangeRate":0.010114}],"exchange":"NASDAQ","name":"吉利德科学","nameEN":"Gilead Sciences"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.0","shortVersion":"4.36.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"吉利德科学(GILD)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供吉利德科学(GILD)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"吉利德科学,GILD,吉利德科学股票,吉利德科学股票老虎,吉利德科学股票老虎国际,吉利德科学行情,吉利德科学股票行情,吉利德科学股价,吉利德科学股市,吉利德科学股票价格,吉利德科学股票交易,吉利德科学股票购买,吉利德科学股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"吉利德科学(GILD)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供吉利德科学(GILD)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}